Tuspetinib
Tuspetinib is an oral kinase inhibitor from Aptose Biosciences Inc., in registered phase 2 trials for myelodysplastic syndromes / neoplasms, chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms.
Overview
Tuspetinib is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Aptose Biosciences Inc., in myelodysplastic syndromes / neoplasms, chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms. A kinase inhibitor: the name stem -tinib marks a small molecule that blocks a tyrosine kinase driving tumour growth. The registry record does not state which kinase unless named in the trial entries below. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A kinase inhibitor: the name stem -tinib marks a small molecule that blocks a tyrosine kinase driving tumour growth. The registry record does not state which kinase unless named in the trial entries below.
1.Tuspetinib slips into a pocket on its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"Tuspetinib" OR ABSTRACT:"Tuspetinib" OR TITLE:"HM43239" OR ABSTRACT:"HM43239") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Tuspetinib, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentBexmarilimab
Shares Chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms, Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentJBI-802
Shares Chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms and the tags pipeline, registry-only.
- TreatmentARD103
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentSabatolimab
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentSpartalizumab
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentAdavosertib
Shares the tags pipeline, registry-only.
- TreatmentAlisertib
Shares the tags pipeline, registry-only.
- TreatmentAMO959
Shares the tags pipeline, registry-only.